Showing results (2281-2290 of 3,011) with videos related to

Sort By:
Pageof 302
Practical Radiation Oncology|December 6, 2020
Accreditation Program for Excellence (APEx): A Catalyst for Quality ImprovementDavid S Hong, Thomas Boike, Samantha Dawes, et al.
The Journal of Biological Chemistry|January 11, 2011
Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturationMatthew A Smith, Gabriela Wright, Jian Wu, et al.
Immunity, Inflammation and Disease|April 5, 2016
Differential changes in gene expression in human neutrophils following TNF-α stimulation: Up-regulation of anti-apoptotic proteins and down-regulation of proteins involved in death receptor signalingDirekrit Chiewchengchol, Helen L Wright, Huw B Thomas, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 17, 2003
Prostate tumor microenvironment alters immune cells and prevents long-term survival in an orthotopic mouse model following flt3-ligand/CD40-ligand immunotherapyRichard P Ciavarra, Daniel A Holterman, Roy R Brown, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 22, 2008
Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implicationsMário G Pessôa, Venancio A F Alves, Alda Wakamatsu, et al.
International Journal of Oncology|September 21, 2000
Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapyL S Incognito, L H Cazares, P F Schellhammer, et al.
Journal of Hepatology|April 27, 2000
HCV-related fibrosis progression following liver transplantation: increase in recent yearsM Berenguer, L Ferrell, J Watson, et al.
Pediatric Research|June 15, 1999
GB virus C (GBV-C/HGV) and E2 antibodies in children preliver and postliver transplantO Elkayam, H M Hassoba, L D Ferrell, et al.
Immunity|November 1, 1994
Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene inductionK C Chin, C Mao, C Skinner, et al.
Cancer Gene Therapy|October 7, 2006
Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptorC R J Pameijer, A Navanjo, B Meechoovet, et al.
Pageof 302